Published in J Eval Clin Pract on July 26, 2012
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. J Am Heart Assoc (2013) 1.15
Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies. J Interv Card Electrophysiol (2013) 1.02
Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res (2014) 0.87
LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin? Clin Med Rev Vasc Health (2013) 0.75
Utilization and prescribing patterns of direct oral anticoagulants. Int J Gen Med (2017) 0.75
Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. Pharmacotherapy (2011) 1.16
A summer research training program to foster PharmD students' interest in research. Am J Pharm Educ (2008) 1.11
Very important pharmacogene summary ADRB2. Pharmacogenet Genomics (2010) 0.94
Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics (2009) 0.93
The impurities of capreomycin make a difference in the safety and pharmacokinetic profiles. Int J Antimicrob Agents (2003) 0.85
Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information. J Med Libr Assoc (2016) 0.77